Virtus ETF Advisers’s Oric Pharmaceuticals ORIC Stock Holding History

Virtus ETF Advisers’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,434	Closed	-$68.1K	–	678
2024 Q4	$68.1K	Sell	8,434 -3,563	-30%	-$32.7K	0.03%	395
2024 Q3	$123K	Buy	11,997 +210	+2%	+$2.08K	0.06%	349
2024 Q2	$83.3K	Buy	11,787 +2,350	+25%	+$21K	0.04%	389
2024 Q1	$130K	Sell	9,437 -648	-6%	-$7.7K	0.07%	341
2023 Q4	$92.8K	Buy	+10,085	New	+$72.9K	0.06%	392
2022 Q2	–	Sell	-12,914	Closed	-$69K	–	463
2022 Q1	$69K	Sell	12,914 -763	-6%	-$6.87K	0.03%	353
2021 Q4	$201K	Buy	13,677 +2,895	+27%	+$45.1K	0.08%	207
2021 Q3	$225K	Sell	10,782 -567	-5%	-$11.5K	0.1%	240
2021 Q2	$201K	Buy	11,349 +2,955	+35%	+$64.8K	0.08%	343
2021 Q1	$206K	Buy	8,394 +147	+2%	+$4.64K	0.09%	324
2020 Q4	$279K	Buy	+8,247	New	+$237K	0.12%	248

Other funds holding ORIC

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Alkeon Capital Management

Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return